ESR1 and breast cancer: Triple-negative breast cancers (TNBC) constitute a heterogeneous group of breast cancers, defined histologically by the lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2).